Discover 289 paid clinical trials in Idaho. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Idaho provides a wide range of paid clinical research opportunities for both healthy volunteers and people with specific health conditions. Facilities in Boise, Idaho Falls, and Meridian are actively seeking participants, offering access to new therapies and specialized care.
Filter
1
Filter results
Results: 289
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Location: Rockport ME, Belfast ME, Damariscotta ME, Augusta ME,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07018869
Phase3, Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, West Chester PA, Kingston, Miami FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07177339
Phase3, Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
for
Primary Membranous Nephropathy
Location: New York NY, Miami FL, Winter Park FL, Orlando FL,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07204275
Phase2, Phase3, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Stony Brook NY, Commack NY, Berlin Corners VT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT06931340
Phase3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase3, Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Waterford CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06769126
Phase2, Recruiting
Reducing Crises and Suicide Within the Idaho Army National Guard
for
Crisis Response Plan, Crisis Intervention
Location: Boise ID
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT07032636
Recruiting
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
for
Lung Non-Small Cell Carcinoma
Location: Stony Brook NY, Neptune City NJ, Red Bank NJ, Brick NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07388524
Phase3, Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for
Alzheimer Disease, Dementia, Plaque, Amyloid
Location: Newton MA, Springfield NJ, Aventura FL, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55+
Code: NCT07602582
Phase3, Recruiting
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
for
Pneumococcal Disease
Location: Fall River MA, East Syracuse NY, Richmond VA,
Sponsor: Pfizer
Sex: All
Age: 1 - 17
Code: NCT07660198
Phase3, Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Portland ME, South Portland ME, Boston MA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase3, Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: Boston MA, New York NY, Newport News VA, Syracuse NY,
Sponsor: Insulet Corporation
Sex: All
Age: 18 - 70+
Code: NCT07521475
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Moncton, Chicoutimi, New York NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase3, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, The Bronx NY, Wilkes-Barre PA, Syracuse NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase2, Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Boston MA, Hawthorne NY, Richmond VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase2, Phase3, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma